ST266 Versus Standard Care In Treating Partial Thickness Burns

Inclusion Criteria: * A signed IRB (Institutional Review Board)- approved Informed Consent Form; * 18 - 65 years of age; * Two (2) similar, non-contiguous, partial-thickness burn wounds between 50 cm2 and 250 cm2 in area with blisters removed in a Total Body Surface Area(TBSA) burn of less than or equal to 40% TBSA; * Burns must be thermal burns of flame or scald etiology; * Patient must present to the burn center within 8 hours of injury; * Normal creatinine and bilirubin levels; * If capable of bearing children, patient must be using a medically accepted means of birth control and have a negative serum pregnancy test; * Willing to participate in the clinical study and comply with the requirements of the trial. Exclusion Criteria: * The two (2) chosen wounds must not be full-thickness (extending through the dermis into the subcutaneous tissue); * Thermal burn from chemical, electrical or radiation causes; * Neither the study wound nor the comparator wound can be \< 50 cm2 or \>250 cm2 in size and cannot be on the face or hands; * Patients with significant pulmonary injury, i.e., smoke inhalation injury requiring ventilator support; * Patients with diabetes; * Patients with any immune deficiency including current treatment with corticosteroid medication, chemotherapeutic agents, anti-viral therapy, or concurrent radiation therapy within 30 days of signing the informed consent; * Abnormal bilirubin, liver function studies (i.e., Alanine transaminase (ALT); Aspartate transaminase (AST)\> 2.0 times normal); * Abnormal serum creatinine, receiving hemodialysis or peritoneal dialysis; * Active cancer or a history of cancer in the 5 years prior to signing the informed consent form (history of basal cell carcinoma is allowed); * Psychiatric condition or substance abuse which in the Investigator's opinion may pose a threat to patient compliance; * History of non-compliance with treatment or clinical visit attendance. * Patients whose burns were previously treated with anything other than ice, cold water or dry dressing. * Participation in an investigational trial within 30 days of study entry.